EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How can the gut microbiome be targeted to fight multidrug-resistant organisms?

Benjamin Davido, Blair Merrick, Ed Kuijper, Nicolas Benech, Lena M Biehl, Silvia Corcione, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI)

The Lancet Microbe · 2025-08 · 6 (8) · 101063

DOI: 10.1016/j.lanmic.2024.101063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2025-08. Verfasst von Benjamin Davido und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Raymond-Poincaré University Hospital, AP-HP, Paris-Saclay University, Garches, France. Electronic address: benjamin.d…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drug Resistance, Multiple, Bacterial, Bacterial Infections, Bacteria. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of antimicrobial resistance presents a challenge to public health, undermines the efficacy of antibiotics, and compromises the management of infectious diseases. Gut colonisation by multidrug-resistant organisms, such as multidrug-resistant Enterobacterales and vancomycin-resistant enterococci, is associated with increased morbidity and mortality rates, as well as health-care costs. Of late, the role of the gut microbiome in combating colonisation by multidrug-resistant organisms, which could precede invasive infection, has garnered interest. Innovative interventions, including faecal microbiota transplantation, probiotics, phage therapy, and bacterial consortia, represent potential preventive or therapeutic options to counteract colonisation by multidrug-resistant organisms. In this Personal View, we have synthesised the current findings on these interventions and elucidated their potential as solutions to the crisis of antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrug Resistance, Multiple, BacterialBacterial InfectionsBacteriaHumansAnti-Bacterial AgentsProbioticsFecal Microbiota TransplantationPhage TherapyVancomycin-Resistant Enterococci

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Infectious Diseases Department, Raymond-Poincaré University Hospital, AP-HP, Paris-Saclay University, Garches, France. Electronic address: benjamin.davido@aphp.fr.
  • Clinical Infection and Diagnostics Research Group, Guy's and St Thomas' NHS Foundation Trust and King's College, London, UK.
  • Center for Microbiota Analysis and Therapeutics, Leiden University Center for Infectious Disease, Leiden University Medical Center, Leiden, Netherlands.
  • Hepato-Gastroenterology Department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Lyon GEM Microbiota Study Group, Lyon, France; Claude Bernard Lyon 1 University, Centre de Recherche en Cancérologie…
  • Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Bonn-Cologne, Cologne, Germany.
  • Department of Medical Sciences, University of Turin, Torino, Italy; Tufts University School of Medicine, Boston, MA, USA.

Zitieren

APA

Davido, B., Merrick, B., Kuijper, E., Benech, N., Biehl, L. M., Corcione, S., & European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI) (2025). How can the gut microbiome be targeted to fight multidrug-resistant organisms?. The Lancet Microbe, 6(8), 101063. https://doi.org/10.1016/j.lanmic.2024.101063

Vancouver

Davido B, Merrick B, Kuijper E, Benech N, Biehl LM, Corcione S, et al. How can the gut microbiome be targeted to fight multidrug-resistant organisms?. The Lancet Microbe. 2025;6(8):101063. doi:10.1016/j.lanmic.2024.101063

BibTeX
@article{Davido2025,
  author = {Davido, Benjamin and Merrick, Blair and Kuijper, Ed and Benech, Nicolas and Biehl, Lena M and Corcione, Silvia and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI)},
  title = {How can the gut microbiome be targeted to fight multidrug-resistant organisms?},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {8},
  pages = {101063},
  doi = {10.1016/j.lanmic.2024.101063}
}
Kostenlos starten →